|
End-of-day quote
Taiwan S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 53.90 TWD | +3.65% |
|
+0.19% | -9.11% |
| Market Cap | 6.48B 203M 174M 162M 149M 280M 19.42B 285M 1.92B 750M 9.73B 762M 745M 32.22B | P/E 2024 |
52.9x | P/E 2025 | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.6B 238M 204M 190M 174M 328M 22.76B 334M 2.25B 879M 11.41B 893M 874M 37.76B | EV / Sales 2024 |
2x | EV / Sales 2025 | 1.7x |
| Free-Float |
78.86% | Yield 2024 |
4.36% | Yield 2025 | 5.06% |
| 1 day | +3.65% | ||
| 1 week | +0.19% | ||
| Current month | +6.31% | ||
| 1 month | +3.65% | ||
| 3 months | +4.46% | ||
| 6 months | -4.94% | ||
| Current year | -9.11% |
| 1 week | 51.2 |  | 54.6 |
| 1 month | 48.5 | | 55.5 |
| Current year | 48.5 | | 62.5 |
| 1 year | 48.5 | | 70.1 |
| 3 years | 48.5 | | 121 |
| 5 years | 44.2 | | 121 |
| 10 years | 29.75 | | 121 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CEO | Chief Executive Officer | - | 01/01/1996 |
Yue Chen Lo
DFI | Director of Finance/CFO | - | 14/04/2003 |
Chin Yuan Lin
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
CHM | Chairman | - | 01/01/1996 |
Che Jen Chuang
BRD | Director/Board Member | - | 18/06/2012 |
Hung Min Hsieh
BRD | Director/Board Member | - | 28/08/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.65% | +0.19% | -17.84% | -39.10% | 196M | |
| -2.81% | +2.93% | +76.40% | +126.23% | 1,141B | |
| -2.21% | +2.02% | +49.50% | +59.77% | 659B | |
| -1.56% | +4.39% | +25.19% | +74.37% | 470B | |
| +1.20% | +1.72% | +42.89% | +45.78% | 366B | |
| -0.61% | +1.72% | +25.21% | +41.34% | 302B | |
| +0.32% | +3.30% | +2.60% | +13.42% | 254B | |
| -1.95% | +3.80% | +46.31% | +66.37% | 239B | |
| -1.10% | -1.12% | -14.91% | -52.66% | 207B | |
| -2.82% | +3.84% | +20.81% | +88.89% | 183B | |
| Average | -0.62% | +4.18% | +25.62% | +42.44% | 382.12B | |
| Weighted average by Cap. | -1.29% | +4.31% | +43.81% | +71.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.73B 148M 127M 118M 109M 204M 14.17B 208M 1.4B 547M 7.1B 556M 544M 23.51B | 4.85B 152M 130M 121M 111M 209M 14.53B 213M 1.44B 561M 7.28B 570M 558M 24.11B |
| Net income | 157M 4.92M 4.22M 3.93M 3.61M 6.78M 471M 6.92M 46.66M 18.19M 236M 18.49M 18.09M 782M | 441M 13.81M 11.82M 11.03M 10.12M 19.02M 1.32B 19.4M 131M 51.02M 662M 51.85M 50.73M 2.19B |
| Net Debt | 1.2B 37.44M 32.06M 29.91M 27.45M 51.57M 3.58B 52.59M 355M 138M 1.8B 141M 138M 5.94B | 1.12B 34.92M 29.9M 27.9M 25.6M 48.1M 3.34B 49.05M 331M 129M 1.67B 131M 128M 5.54B |
Employees
-
Sector
Pharmaceuticals
Calendar
24/08
Ex-dividend date - 3 TWD
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | TWD 53.90 | +3.65% | 1,114,489 |
| 19/08/26 | TWD 52.00 | -0.57% | 262,967 |
| 18/08/26 | TWD 52.30 | +0.19% | 339,088 |
| 17/08/26 | TWD 52.20 | +1.56% | 429,944 |
| 14/08/26 | TWD 51.40 | -3.75% | 1,081,093 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4746 Stock
Select your edition
All financial news and data tailored to specific country editions
